Intersect ENT - PDFSEARCH.IO - Document Search Engine

Intersect ENT
Results: 36

#	Item
21	Intersect ENT Announces Appointment of Cynthia L. Lucchese to Board of Directors Menlo Park, Calif. – July 11, 2014 – Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-07-11 15:43:46
22	Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors MENLO PARK, Calif., April 9, [removed]Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-04-09 20:24:03 Healthcare Technology Otolaryngology Sinusitis Sinus Norwest Medicine Health CareFusion
23	Media Contact: Nicole Osmer[removed]removed] Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes For Sinus Surgery Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:17 Headaches Rhinology Sinusitis Otolaryngology Sinus Medicine Health General practice
24	Intersect ENT to Present at the 32nd Annual J.P. Morgan Healthcare Conference Menlo Park, Calif. – Jan. 8, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:12:02 General practice Headaches Sinusitis Sinus Otolaryngology Medtronic Medicine Health Rhinology
25	Intersect ENT Announces Enrollment of First Patient In Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis Menlo Park, Calif. – Dec. 29, 2014 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicate Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-12-29 18:58:43 Anatomy Sinus Medicine Rhinology Otolaryngology
26	Intersect ENT Appoints Chas McKhann as Chief Commercial Officer Menlo Park, Calif. – February 2, 2015––Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-02-03 12:17:27 Headaches Sinusitis Otolaryngology Sinus Drug-eluting stent Medicine Rhinology General practice
27	Intersect ENT Added To Russell 2000 Index Menlo Park, Calif. – Oct. 1, 2014 – Intersect ENT (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-10-01 16:51:05 Sinusitis Otolaryngology Sinus Medicine Russell Indexes Russell
28	Intersect ENT Named One of the “Fierce 15” Most Promising Private Companies by FierceMedicalDevices Menlo Park, Calif. – Oct. 15, 2013 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:02 General practice Headaches Sinusitis Sinus Otolaryngology U.S. Venture Partners Medtronic Medicine Health Rhinology
29	Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients RESOLVE Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Post-Sinus Surgery Patients wi Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:35 Headaches Sinusitis Otolaryngology Sinus Balloon sinuplasty Medicine Rhinology General practice
30	Intersect ENT Named One of Forbes Magazine’s “America’s Most Promising Companies” of 2014 Menlo Park, Calif. – Jan. 23, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:37 General practice Headaches Sinusitis Sinus Otolaryngology Medtronic Mometasone furoate Medicine Health Rhinology

UPDATE